Condensed Consolidated Statements of Stockholders' Deficit - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balances at Dec. 31, 2023	$ 361	$ 276,393	$ (308,819)	$ (32,065)
Balances (in shares) at Dec. 31, 2023	36,122,932
Exercise of stock options	$ 1	129		130
Exercise of stock options (in shares)	37,282
Withholdings for taxes related to net share settlement of equity awards, shares	(4,222)
Stock-based compensation expense		1,869		1,869
Net income (loss)			(16,035)	(16,035)
Balances at Jun. 30, 2024	$ 362	278,391	(324,854)	(46,101)
Balances (in shares) at Jun. 30, 2024	36,155,992
Balances at Mar. 31, 2024	$ 361	276,969	(333,840)	(56,510)
Balances (in shares) at Mar. 31, 2024	36,132,117
Exercise of stock options	$ 1	87		88
Exercise of stock options (in shares)	23,875
Stock-based compensation expense		1,335		1,335
Net income (loss)			8,986	8,986
Balances at Jun. 30, 2024	$ 362	278,391	(324,854)	(46,101)
Balances (in shares) at Jun. 30, 2024	36,155,992
Balances at Dec. 31, 2024	$ 362	279,354	(327,735)	(48,019)
Balances (in shares) at Dec. 31, 2024	36,183,067
Issuance of Common Stock upon release of restricted stock units, net of tax withholdings		(14)		(14)
Issuance of Common Stock upon release of restricted stock units, net of tax withholdings (In shares)	10,412
Stock-based compensation expense		1,356		1,356
Net income (loss)			(22,826)	(22,826)
Balances at Jun. 30, 2025	$ 362	280,696	(350,561)	(69,503)
Balances (in shares) at Jun. 30, 2025	36,193,479
Balances at Mar. 31, 2025	$ 362	280,121	(334,266)	(53,783)
Balances (in shares) at Mar. 31, 2025	36,193,479
Stock-based compensation expense		575		575
Net income (loss)			(16,295)	(16,295)
Balances at Jun. 30, 2025	$ 362	$ 280,696	$ (350,561)	$ (69,503)
Balances (in shares) at Jun. 30, 2025	36,193,479